Proteomics in the investigation of HIV-1 interactions with host proteins

Proteomics - Clinical Applications

Volumn 9, Issue 1-2, 2015, Pages 221-234

  Li, Ming ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cellular factor; HIV 1; Host protein; MS; Viral protein

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; PROTEOME; REGULATOR PROTEIN; STRUCTURAL PROTEIN; BIOLOGICAL MARKER;

CELLULAR PARAMETERS; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFE CYCLE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEOMICS; REGULATORY MECHANISM; REVIEW; VIRION; VIRUS CELL INTERACTION; VIRUS GENOME; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; PROCEDURES; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BIOMARKERS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEOME; PROTEOMICS;

EID: 84946160746     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400101     Document Type: Review

References (139)

1. Clavel, F., Hance, A. J., HIV drug resistance. N. Engl. J. Med. 2004, 350, 1023-1035.
2. Frankel, A. D., Young, J. A., HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 1998, 67, 1-25.
3. Friedrich, B. M., Dziuba, N., Li, G., Endsley, M. A. et al., Host factors mediating HIV-1 replication. Virus Res. 2011, 161, 101-114.
4. Sattentau, Q. J., Weiss, R. A., The CD4 antigen: physiological ligand and HIV receptor. Cell 1988, 52, 631-633.
5. Moore, J. P., Kitchen, S. G., Pugach, P., Zack, J. A., The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 2004, 20, 111-126.
6. Cherepanov, P., Maertens, G., Proost, P., Devreese, B. et al., HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 2003, 278, 372-381.
7. Llano, M., Saenz, D. T., Meehan, A., Wongthida, P. et al., An essential role for LEDGF/p75 in HIV integration. Science 2006, 314, 461-464.
8. Wei, P., Garber, M. E., Fang, S. M., Fischer, W. H., Jones, K. A., A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92, 451-462.
9. Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G. et al., Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001, 107, 55-65.
10. Flexner, C., HIV drug development: the next 25 years. Nat. Rev. Drug Discov. 2007, 6, 959-966.
11. Dorr, P., Westby, M., Dobbs, S., Griffin, P. et al., Maraviroc (UK-427857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob. Agents Chemother. 2005, 49, 4721-4732.
12. Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N. et al., Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319, 921-926.
13. Konig, R., Zhou, Y., Elleder, D., Diamond, T. L. et al., Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135, 49-60.
14. Zhou, H., Xu, M., Huang, Q., Gates, A. T. et al., Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4, 495-504.
15. Bushman, F. D., Malani, N., Fernandes, J., D'Orso, I. et al., Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 2009, 5, e1000437.
16. Aebersold, R., Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
17. Han, X., Aslanian, A., Yates, J. R., 3rd, Mass spectrometry for proteomics. Curr. Opin. Chem. Biol. 2008, 12, 483-490.
18. Ringrose, J. H., Jeeninga, R. E., Berkhout, B., Speijer, D., Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J. Virol. 2008, 82, 4320-4330.
19. Chan, E. Y., Qian, W. J., Diamond, D. L., Liu, T. et al., Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J. Virol. 2007, 81, 7571-7583.
20. Rasheed, S., Yan, J. S., Lau, A., Chan, A. S., HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One 2008, 3, e3003.
21. Kraft-Terry, S. D., Engebretsen, I. L., Bastola, D. K., Fox, H. S. et al., Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage. J. Proteome Res. 2011, 10, 2852-2862.
22. Chan, E. Y., Sutton, J. N., Jacobs, J. M., Bondarenko, A. et al., Dynamic host energetics and cytoskeletal proteomes in human immunodeficiency virus type 1-infected human primary CD4 cells: analysis by multiplexed label-free mass spectrometry. J. Virol. 2009, 83, 9283-9295.
23. Navare, A. T., Sova, P., Purdy, D. E., Weiss, J. M. et al., Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 2012, 429, 37-46.
24. Wojcechowskyj, J. A., Lee, J. Y., Seeholzer, S. H., Doms, R. W., Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. PLoS One 2011, 6, e24918.
25. Wojcechowskyj, J. A., Didigu, C. A., Lee, J. Y., Parrish, N. F. et al., Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry. Cell Host Microbe 2013, 13, 613-623.
26. Britton, L. M., Sova, P., Belisle, S., Liu, S. et al., A proteomic glimpse into the initial global epigenetic changes during HIV infection. Proteomics 2014, 14, 2226-2230.
27. Schweitzer, C. J., Jagadish, T., Haverland, N., Ciborowski, P., Belshan, M., Proteomic analysis of early HIV-1 nucleoprotein complexes. J. Proteome Res. 2013, 12, 559-572.
28. DeBoer, J., Jagadish, T., Haverland, N. A., Madson, C. J. et al., Alterations in the nuclear proteome of HIV-1 infected T-cells. Virology 2014, 468-470C, 409-420.
29. Monette, A., Pante, N., Mouland, A. J., HIV-1 remodels the nuclear pore complex. J. Cell Biol. 2011, 193, 619-631.
30. Ciborowski, P., Kadiu, I., Rozek, W., Smith, L. et al., Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 2007, 363, 198-209.
31. Kadiu, I., Ricardo-Dukelow, M., Ciborowski, P., Gendelman, H. E., Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J. Immunol. 2007, 178, 6404-6415.
32. Nguyen, D. G., Booth, A., Gould, S. J., Hildreth, J. E., Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 2003, 278, 52347-52354.
33. Kadiu, I., Narayanasamy, P., Dash, P. K., Zhang, W., Gendelman, H. E., Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J. Immunol. 2012, 189, 744-754.
34. Li, M., Aliotta, J. M., Asara, J. M., Tucker, L. et al., Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells. Proteomics 2012, 12, 2203-2211.
35. Hatziioannou, T., Perez-Caballero, D., Cowan, S., Bieniasz, P. D., Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J. Virol. 2005, 79, 176-183.
36. Willetts, K. E., Rey, F., Agostini, I., Navarro, J. M. et al., DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism. J. Virol. 1999, 73, 1682-1688.
37. Zhang, F., Zang, T., Wilson, S. J., Johnson, M. C., Bieniasz, P. D., Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog. 2011, 7, e1002119.
38. Thali, M., Bukovsky, A., Kondo, E., Rosenwirth, B. et al., Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372, 363-365.
39. Misumi, S., Fuchigami, T., Takamune, N., Takahashi, I. et al., Three isoforms of cyclophilin A associated with human immunodeficiency virus type 1 were found by proteomics by using two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Virol. 2002, 76, 10000-10008.
40. Chertova, E., Chertov, O., Coren, L. V., Roser, J. D. et al., Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80, 9039-9052.
41. Linde, M. E., Colquhoun, D. R., UbaidaMohien, C., Kole, T. et al., The conserved set of host proteins incorporated into HIV-1 virions suggests a common egress pathway in multiple cell types. J. Proteome Res. 2013, 12, 2045-2054.
42. Freed, E. O., HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998, 251, 1-15.
43. Bell, N. M., Lever, A. M., HIV Gag polyprotein: processing and early viral particle assembly. Trends Microbiol. 2013, 21, 136-144.
44. Sundquist, W. I., Krausslich, H. G., HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2012, 2, a006924.
45. Ver Plank, L., Bouamr, F., La Grassa, T. J., Agresta, B. et al., Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. USA 2001, 98, 7724-7729.
46. Cen, S., Guo, F., Niu, M., Saadatmand, J. et al., The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 2004, 279, 33177-33184.
47. Stremlau, M., Perron, M., Lee, M., Li, Y. et al., Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. USA 2006, 103, 5514-5519.
48. Engeland, C. E., Brown, N. P., Borner, K., Schumann, M. et al., Proteome analysis of the HIV-1 Gag interactome. Virology 2014, 460-461, 194-206.
49. Emdad, L., Das, S. K., Dasgupta, S., Hu, B. et al., AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis. Adv. Cancer Res. 2013, 120, 75-111.
50. Engeland, C. E., Oberwinkler, H., Schumann, M., Krause, E. et al., The cellular protein lyric interacts with HIV-1 Gag. J. Virol. 2011, 85, 13322-13332.
51. Li, J., Tang, H., Mullen, T. M., Westberg, C. et al., A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc. Natl. Acad. Sci USA 1999, 96, 709-714.
52. Bolinger, C., Sharma, A., Singh, D., Yu, L., Boris-Lawrie, K., RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions. Nucleic Acids Res. 2010, 38, 1686-1696.
53. Roy, B. B., Hu, J., Guo, X., Russell, R. S. et al., Association of RNA helicase a with human immunodeficiency virus type 1 particles. J. Biol. Chem. 2006, 281, 12625-12635.
54. Spitaler, M., Cantrell, D. A., Protein kinase C and beyond. Nat. Immunol. 2004, 5, 785-790.
55. McKernan, L. N., Momjian, D., Kulkosky, J., Protein Kinase C: one Pathway towards the Eradication of Latent HIV-1 Reservoirs. Adv. Virol. 2012, 2012, 805347.
56. Kudoh, A., Takahama, S., Sawasaki, T., Ode, H. et al., The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions. Retrovirology 2014, 11, 9.
57. Martin-Serrano, J., Zang, T., Bieniasz, P. D., Role of ESCRT-I in retroviral budding. J. Virol. 2003, 77, 4794-4804.
58. von Schwedler, U. K., Stuchell, M., Muller, B., Ward, D. M. et al., The protein network of HIV budding. Cell 2003, 114, 701-713.
59. Strack, B., Calistri, A., Craig, S., Popova, E., Gottlinger, H. G., AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003, 114, 689-699.
60. Villace, P., Marion, R. M., Ortin, J., The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res. 2004, 32, 2411-2420.
61. Mouland, A. J., Mercier, J., Luo, M., Bernier, L. et al., The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J. Virol. 2000, 74, 5441-5451.
62. Chatel-Chaix, L., Clement, J. F., Martel, C., Beriault, V. et al., Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol. Cell. Biol. 2004, 24, 2637-2648.
63. Milev, M. P., Ravichandran, M., Khan, M. F., Schriemer, D. C., Mouland, A. J., Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1. Front. Microbiol. 2012, 3, 367.
64. Hill, M., Tachedjian, G., Mak, J., The packaging and maturation of the HIV-1 Pol proteins. Curr. HIV Res. 2005, 3, 73-85.
65. Hu, W. S., Hughes, S. H., HIV-1 reverse transcription. Cold Spring Harb. Perspect. Med. 2012, 2, doi: 10.1101/cshperspect.a006882
66. Craigie, R., Bushman, F. D., HIV DNA integration. Cold Spring Harb. Perspect. Med. 2012, 2, a006890.
67. Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K. et al., LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 2003, 278, 33528-33539.
68. Jiang, M., Mak, J., Ladha, A., Cohen, E. et al., Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 1993, 67, 3246-3253.
69. Cen, S., Khorchid, A., Javanbakht, H., Gabor, J. et al., Incorporation of lysyl-tRNAsynthetase into human immunodeficiency virus type 1. J. Virol. 2001, 75, 5043-5048.
70. Meerschaert, K., Remue, E., De Ganck, A., Staes, A. et al., The tandem PDZ protein Syntenin interacts with the aminoacyltRNAsynthetase complex in a lysyl-tRNAsynthetase-dependent manner. J. Proteome Res. 2008, 7, 4962-4973.
71. Gordon-Alonso, M., Rocha-Perugini, V., Alvarez, S., Moreno-Gonzalo, O. et al., The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry. MolBiol Cell 2012, 23, 2253-2263.
72. Belshan, M., Schweitzer, C. J., Donnellan, M. R., Lu, R., Engelman, A., In vivo biotinylation and capture of HIV-1 matrix and integrase proteins. J. Virol. Methods 2009, 159, 178-184.
73. Schweitzer, C. J., Matthews, J. M., Madson, C. J., Donnellan, M. R. et al., Knockdown of the cellular protein LRPPRC attenuates HIV-1 infection. PLoS One 2012, 7, e40537.
74. McKee, C. J., Kessl, J. J., Shkriabai, N., Dar, M. J. et al., Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J. Biol. Chem. 2008, 283, 31802-31812.
75. Brik, A., Wong, C. H., HIV-1 protease: mechanism and drug discovery. Org. Biomol. Chem. 2003, 1, 5-14.
76. Nie, Z., Phenix, B. N., Lum, J. J., Alam, A. et al., HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ 2002, 9, 1172-1184.
77. Castello, A., Franco, D., Moral-Lopez, P., Berlanga, J. J. et al., HIV-1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. PLoS One 2009, 4, e7997.
78. Gevaert, K., Goethals, M., Martens, L., Van Damme, J. et al., Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 2003, 21, 566-569.
79. Impens, F., Timmerman, E., Staes, A., Moens, K. et al., A catalogue of putative HIV-1 protease host cell substrates. Biol. Chem. 2012, 393, 915-931.
80. Raghavendra, N. K., Shkriabai, N., Graham, R., Hess, S. et al., Identification of host proteins associated with HIV-1 preintegration complexes isolated from infected CD4+ cells. Retrovirology 2010, 7, 66.
81. Capon, D. J., Ward, R. H., The CD4-gp120 interaction and AIDS pathogenesis. Annu. Rev. Immunol. 1991, 9, 649-678.
82. Blumenthal, R., Durell, S., Viard, M., HIV entry and envelope glycoprotein-mediated fusion. J. Biol. Chem. 2012, 287, 40841-40849.
83. Wyatt, R., Sodroski, J., The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 280, 1884-1888.
84. Go, E. P., Chang, Q., Liao, H. X., Sutherland, L. L. et al., Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J. Proteome Res. 2009, 8, 4231-4242.
85. Wang, L., Qin, Y., Ilchenko, S., Bohon, J. et al., Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry. Biochemistry 2010, 49, 9032-9045.
86. Honarmand Ebrahimi, K., West, G. M., Flefil, R., Mass Spectrometry approach and ELISA reveal the effect of codon optimization on N-linked glycosylation of HIV-1 gp120. J. Proteome Res. 2014, 14, 5801-5811.
87. Molina, L., Grimaldi, M., Robert-Hebmann, V., Espert, L.et al., Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope. Proteomics 2007, 7, 3116-3130.
88. Pollard, V. W., Malim, M. H., The HIV-1 Rev protein. Annu. Rev. Microbiol. 1998, 52, 491-532.
89. Cullen, B. R., Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 2003, 28, 419-424.
90. Hofmann, W., Reichart, B., Ewald, A., Muller, E. et al., Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J. Cell Biol. 2001, 152, 895-910.
91. Zolotukhin, A. S., Felber, B. K., Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev. J. Virol. 1999, 73, 120-127.
92. Washburn, M. P., Wolters, D., Yates, J. R., 3rd, Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
93. Naji, S., Ambrus, G., Cimermancic, P., Reyes, J. R. et al., Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol. Cell. Proteomics 2012, 11, M111 015313.
94. Kula, A., Guerra, J., Knezevich, A., Kleva, D. et al., Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function. Retrovirology 2011, 8, 60.
95. Woolaway, K., Asai, K., Emili, A., Cochrane, A., hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. Retrovirology 2007, 4, 28.
96. Fukuhara, T., Hosoya, T., Shimizu, S., Sumi, K. et al., Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc. Natl. Acad. Sci. USA 2006, 103, 11329-11333.
97. Marchand, V., Santerre, M., Aigueperse, C., Fouillen, L. et al., Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K. RNA Biol. 2011, 8, 325-342.
98. Debaisieux, S., Rayne, F., Yezid, H., Beaumelle, B., The ins and outs of HIV-1 Tat. Traffic 2012, 13, 355-363.
99. Romani, B., Engelbrecht, S., Glashoff, R. H., Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J. Gen. Virol. 2010, 91, 1-12.
100. Feng, S., Holland, E. C., HIV-1 tat trans-activation requires the loop sequence within tar. Nature 1988, 334, 165-167.
101. Coiras, M., Camafeita, E., Urena, T., Lopez, J. A. et al., Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics 2006, 6 Suppl 1, S63-73.
102. Vardabasso, C., Manganaro, L., Lusic, M., Marcello, A., Giacca, M., The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription. Retrovirology 2008, 5, 8.
103. Timani, K. A., Liu, Y., He, J. J., Tip110 interacts with YB-1 and regulates each other's function. BMC Mol. Biol. 2013, 14, 14.
104. Gautier, V. W., Gu, L., O'Donoghue, N., Pennington, S. et al., In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 2009, 6, 47.
105. Jarboui, M. A., Bidoia, C., Woods, E., Roe, B. et al., Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus. PLoS One 2012, 7, e48702.
106. Liao, W., Tan, G., Zhu, Z., Chen, Q. et al., Combined metabonomic and quantitative real-time PCR analyses reveal systems metabolic changes in Jurkat T-cells treated with HIV-1 Tat protein. J. Proteome Res. 2012, 11, 5109-5123.
107. Lopez-Huertas, M. R., Mateos, E., Sanchez Del Cojo, M., Gomez-Esquer, F. et al., The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production. J. Biol. Chem. 2013, 288, 7626-7644.
108. Berro, R., Kehn, K., de laFuente, C., Pumfery, A. et al., Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. J. Virol. 2006, 80, 3189-3204.
109. O'Neill, E., Kuo, L. S., Krisko, J. F., Tomchick, D. R. et al., Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J. Virol. 2006, 80, 1311-1320.
110. Abraham, L., Fackler, O. T., HIV-1 Nef: a multifaceted modulator of T cell receptor signaling. Cell Commun. Signal 2012, 10, 39.
111. Geyer, M., Fackler, O. T., Peterlin, B. M., Structure-function relationships in HIV-1 Nef. EMBO Rep. 2001, 2, 580-585.
112. Janardhan, A., Swigut, T., Hill, B., Myers, M. P., Skowronski, J., HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol. 2004, 2, E6.
113. Mukerji, J., Olivieri, K. C., Misra, V., Agopian, K. A., Gabuzda, D., Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology 2012, 9, 33.
114. Shelton, M. N., Huang, M. B., Ali, S. A., Powell, M. D., Bond, V. C., Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nefexosome release. J. Virol. 2012, 86, 406-419.
115. Bregnard, C., Zamborlini, A., Leduc, M., Chafey, P. et al., Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J. Virol. 2013, 87, 3729-3740.
116. Sheehy, A. M., Gaddis, N. C., Malim, M. H., The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 2003, 9, 1404-1407.
117. Sheehy, A. M., Gaddis, N. C., Choi, J. D., Malim, M. H., Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418, 646-650.
118. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C. et al., The cytidinedeaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424, 94-98.
119. Auclair, J. R., Green, K. M., Shandilya, S., Evans, J. E. et al., Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity. Proteins 2007, 69, 270-284.
120. Marcsisin, S. R., Engen, J. R., Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif. J. Mol. Biol. 2010, 402, 892-904.
121. Marcsisin, S. R., Narute, P. S., Emert-Sedlak, L. A., Kloczewiak, M. et al., On the solution conformation and dynamics of the HIV-1 viral infectivity factor. J. Mol. Biol. 2011, 410, 1008-1022.
122. Yu, X., Yu, Y., Liu, B., Luo, K. et al., Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302, 1056-1060.
123. Jager, S., Kim, D. Y., Hultquist, J. F., Shindo, K. et al., Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 2012, 481, 371-375.
124. Heinzinger, N. K., Bukrinsky, M. I., Haggerty, S. A., Ragland, A. M. et al., The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U S A 1994, 91, 7311-7315.
125. Jowett, J. B., Planelles, V., Poon, B., Shah, N. P. et al., The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 1995, 69, 6304-6313.
126. Barrero, C. A., Datta, P. K., Sen, S., Deshmane, S. et al., HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One 2013, 8, e68376.
127. Margottin, F., Bour, S. P., Durand, H., Selig, L. et al., A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1998, 1, 565-574.
128. Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A., Orenstein, J. M., The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 1990, 64, 621-629.
129. Neil, S. J., Zang, T., Bieniasz, P. D., Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451, 425-430.
130. Douglas, J. L., Viswanathan, K., Mc Carroll, M. N., Gustin, J. K. et al., Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J. Virol. 2009, 83, 7931-7947.
131. Mangeat, B., 0 Gers-Huber, G., Lehmann, M., Zufferey, M. et al., HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 2009, 5, e1000574.
132. Mann, M., Hendrickson, R. C., Pandey, A., Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. 2001, 70, 437-473.
133. Ranish, J. A., Yi, E. C., Leslie, D. M., Purvine, S. O. et al., The study of macromolecular complexes by quantitative proteomics. Nat. Genet. 2003, 33, 349-355.
134. Bonifacino, J. S., Dell'Angelica, E. C., Springer, T. A., Immunoprecipitation. Curr. Protoc. Mol. Biol. 2001, Chapter 10, Unit 10 16.1-16.29.
135. Krogan, N. J., Cagney, G., Yu, H., Zhong, G. et al., Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 2006, 440, 637-643.
136. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 2004, 3, 1154-1169.
137. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 2002, 1, 376-386.
138. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell Proteomics 2006, 5, 573-588.
139. Jager, S., Cimermancic, P., Gulbahce, N., Johnson, J. R. et al., Global landscape of HIV-human protein complexes. Nature 2012, 481, 365-370.